1. 113: Do standardised uptake values from PET-CT scans predict EGFR status of lung tumours?. (January 2015) Authors: Coote, J.H.; Burt, P.A.; Rimmer, C.R.; Bayman, N.; Blackhall, F.; Califano, R.; Chittalia, A.Z.; Faivre-Finn, C.; Harris, M.A.; Lee, L.W.; Pemberton, L.; Sheikh, H.Y.; Summers, Y.; Taylor, P.; Wallace, A.; Shing, E. Journal: Lung cancer Issue: Volume 87(2015)Supplement 1 Page Start: S41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 118 Smoking habits in lung cancer patients and their carers and audit of smoking advice given. (January 2016) Authors: Pankhania, D.; Coote, J.; Burt, P.; Mackereth, P.; Finchett, C.; Orrett, L.; Hodgson, C.; Bayman, N.; Blackhall, F.; Califano, R.; Chan, C.; Faivre-Finn, C.; Harris, M.; Lee, L.; Pemberton, L.; Sheikh, H.; Summers, Y.; Taylor, P. Journal: Lung cancer Issue: Volume 91(2016)Supplement 1 Page Start: S42 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 166 Audit on the characteristics of lung cancer patients who receive BSC (best supportive care). (January 2016) Authors: Harris, M.; Hanna, D.; Faivre-Finn, C.; Bayman, N.; Chittalia, A.; Stout, R.; Pemberton, L.; Califano, R.; Burt, P.; Blackhall, F.; Coote, J.; Sheikh, H.; Summers, Y. Journal: Lung cancer Issue: Volume 91(2016)Supplement 1 Page Start: S60 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 167: Thoracic radiotherapy in extensive stage small cell lung cancer. (January 2015) Authors: Harris, M.A.; Holland, P.; Hogley, R.; Burt, P.A.; Faivre-Finn, C.; Bayman, N.; Pemberton, L.; Lee, L.W.; Coote, J.H.; Sheikh, H.Y.; Chittalia, A.Z.; Blackhall, F.; Califano, R.; Summers, Y.; Taylor, P. Journal: Lung cancer Issue: Volume 87(2015)Supplement 1 Page Start: S61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 32: Screening for brain metastases in non small cell lung cancer (NSCLC). (January 2017) Authors: Harris, M.; Mehdi, M.; Faivre-Finn, C.; Blackhall, F.; Sheikh, H.; Coote, J.; Bayman, N.; Summers, Y.; Califano, R.; Taylor, P.; Pemberton, L. Journal: Lung cancer Issue: Volume 103(2017)Supplement 1 Page Start: S14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 65: Maintenance pemetrexed for non-squamous non-small cell lung cancer (NSCLC): 'real life' outcomes from a UK centre. (January 2017) Authors: Lim, J.; Neocleous, M.; Coote, J.; Woolf, D.; Bayman, N.; Lee, L.; Sheikh, H.; Blackhall, F.; Califano, R.; Summers, Y. Journal: Lung cancer Issue: Volume 103(2017)Supplement 1 Page Start: S30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 66P Real-world data of first-line chemo-immunotherapy for patients with extensive stage SCLC: A multicentre experience from Switzerland and the UK. (December 2022) Authors: Moliner, L.; Zellweger, N.M.; Schmidt, S.M.; Waibel, C.; Froesch, P.R.; Häuptle, P.; Blum, V.; Holer, L.; Frueh, M.; Bhagani, S.; Gray, H-L.J.; Cox, S.; Khalid, T.; Scott, D.C.; Robinson, S.D.; Hennah, L.; Handforth, C.; Mauti, L.A.; Califano, R.; Rothschild, S.I. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 76 Outcomes and tolerability of second line treatment for non small cell lung cancer (NSCLC). (January 2016) Authors: Salih, Z.; Conway, A.M.; Bayman, N.; Blackhall, F.; Califano, R.; Harris, M.; Lee, L.; Sheikh, H.; Taylor, P.; Summers, Y. Journal: Lung cancer Issue: Volume 91(2016)Supplement 1 Page Start: S27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Brigatinib versus crizotinib in patients with ALK inhibitor–naive advanced ALK+ NSCLC: results from the phase 3 ALTA-1L trial. (January 2020) Authors: Califano, R.; Camidge, D.; Kim, H.-R.; Ahn, M.-J.; Yang, J.; Han, J.-Y.; Hochmair, M.; Lee, K.H.; Delmonte, A.; Campelo, M.R. Garcia; Kim, D.-W.; Griesinger, F.; Felip, E.; Spira, A.; Gettinger, S.; Tiseo, M.; Ni, Q.; Zhang, P.; Popat, S. Journal: Lung cancer Issue: Volume 139(2020)Supplement 1 Page Start: S59 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Choice of second-line systemic therapy in stage IV small cell lung cancer (SCLC) – A decision-making analysis amongst European lung cancer experts. (August 2020) Authors: Früh, M.; Panje, C.M.; Reck, M.; Blackhall, F.; Califano, R.; Cappuzzo, F.; Besse, B.; Novello, S.; Garrido, P.; Felip, E.; O'Brien, M.; Paz Ares, L.; de Marinis, F.; Westeel, V.; De Ruysscher, D.; Putora, P.M. Journal: Lung cancer Issue: Volume 146(2020) Page Start: 6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗